Agios Pharmaceuticals, Inc. (AGIO)

NASDAQ: AGIO · Real-Time Price · USD

29.46

+0.74 (2.58%)

At close: Jun 12, 2026, 4:00 PM EDT

29.94

+0.48 (1.63%)

Pre-market: Jun 15, 2026, 7:39 AM EDT

Agios Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 12, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	1,752	1,591	1,878	1,246	1,546	1,786
Market Cap Growth	-4.99%	-15.29%	50.75%	-19.39%	-13.46%	-40.52%
Enterprise Value	742.29	776.75	1,041	540.97	848.06	863.04
Last Close Price	29.46	27.22	32.86	22.27	28.08	32.87
PE Ratio	-	-	2.82	-	-	1.24
PS Ratio	26.53	29.45	51.46	46.45	108.53	-
PB Ratio	1.58	1.33	1.22	1.54	1.40	1.38
EV/Sales Ratio	11.24	14.38	28.53	20.17	59.55	-
Debt / Equity Ratio	0.02	0.02	0.03	0.07	0.07	0.07
Net Debt / Equity Ratio	-0.63	-0.68	-0.54	-0.87	-0.63	-0.71
Net Debt / EBITDA Ratio	1.49	1.74	1.99	1.83	1.83	2.50
Net Debt / FCF Ratio	1.82	2.16	2.14	2.37	2.22	2.27
Asset Turnover	0.05	0.04	0.03	0.02	0.01	0
Inventory Turnover	0.19	0.21	0.18	0.21	0.40	-
Quick Ratio	12.80	10.52	11.06	11.47	12.54	17.12
Current Ratio	14.19	11.46	11.90	12.27	13.30	17.79
Return on Equity (ROE)	-36.71%	-30.20%	57.29%	-36.83%	-19.38%	189.74%
Return on Assets (ROA)	-38.13%	-31.82%	-30.73%	-35.98%	-29.07%	-33.04%
Return on Invested Capital (ROIC)	-120.28%	-86.08%	-95.86%	-145.56%	-96.75%	-117.01%
Return on Capital Employed (ROCE)	-40.62%	-33.76%	-34.74%	-38.28%	-30.47%	-35.42%
Earnings Yield	-	-	35.42%	-	-	80.77%
Buyback Yield / Dilution	-0.25%	-0.14%	-4.02%	-1.57%	9.36%	12.39%
Total Shareholder Return	-0.25%	-0.14%	-4.02%	-1.57%	9.36%	12.39%

SEC Filings: 10-K · 10-Q